British health data startup Gendius has received a UKCA mark for its digital pre-screening technology, the CKD Screening Prioritizer (CSP).  The CSP, which is now a registered medical device in the UK, uses readily available data to predict whether a patient is likely to be experiencing kidney dysfunction or not. This allows clinicians to risk … Continue reading Gendius’ pre-screening CKD tech granted UK regulatory approval